|
WO2003075917A1
(en)
*
|
2002-03-08 |
2003-09-18 |
Signal Pharmaceuticals, Inc. |
Combination therapy for treating, preventing or managing proliferative disorders and cancers
|
|
US7429609B2
(en)
*
|
2002-05-31 |
2008-09-30 |
Eisai R & D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
|
US20050070567A1
(en)
*
|
2002-08-12 |
2005-03-31 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
|
|
AU2003259803B2
(en)
*
|
2002-08-12 |
2007-08-02 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of tuberous sclerosis
|
|
AR045134A1
(es)
*
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
JP2005089457A
(ja)
|
2003-09-03 |
2005-04-07 |
Yung Shin Pharmaceutical Industry Co Ltd |
骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
|
|
JP2007506787A
(ja)
*
|
2003-09-23 |
2007-03-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとしてのピラゾロピロール誘導体
|
|
RU2006117635A
(ru)
*
|
2003-10-24 |
2007-12-10 |
Шеринг Акциенгезельшафт (De) |
Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
|
|
NZ590160A
(en)
|
2003-11-21 |
2012-07-27 |
Array Biopharma Inc |
AKT protein kinase inhibitors
|
|
FR2864084B1
(fr)
*
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
|
US7473783B2
(en)
*
|
2003-12-17 |
2009-01-06 |
Sgx Pharmaceuticals, Inc. |
Bicyclic pyrazolo protein kinase modulators
|
|
US7994196B2
(en)
|
2004-02-12 |
2011-08-09 |
Mitsubishi Tanabe Pharma Corporation |
Indazole compound and pharmaceutical use thereof
|
|
JP4857128B2
(ja)
*
|
2004-02-20 |
2012-01-18 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
新規な化合物
|
|
US7378532B2
(en)
|
2004-03-26 |
2008-05-27 |
Yung Shin Pharmaceutical Ind. Co., Ltd. |
Fused pyrazolyl compound
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
CA2573573A1
(en)
*
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
WO2006088088A1
(ja)
*
|
2005-02-16 |
2006-08-24 |
Astellas Pharma Inc. |
Ｒｏｃｋ阻害剤を含有する疼痛治療剤
|
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US7625890B2
(en)
|
2005-11-10 |
2009-12-01 |
Smithkline Beecham Corp. |
Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
|
|
WO2007058626A1
(en)
*
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
ES2365869T3
(es)
|
2005-11-17 |
2011-10-11 |
OSI Pharmaceuticals, LLC |
COMPUESTOS BICÍCLICOS FUSIONADOS INHIBIDORES DE LA mTOR.
|
|
UA95940C2
(uk)
|
2006-01-17 |
2011-09-26 |
Вертекс Фармасьютикалс Інкорпорейтед |
Азаіндоли як інгібітори кіназ януса
|
|
GB0606429D0
(en)
*
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
|
AR060358A1
(es)
|
2006-04-06 |
2008-06-11 |
Novartis Vaccines & Diagnostic |
Quinazolinas para la inhibicion de pdk 1
|
|
US20070286864A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Buck Elizabeth A |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
|
ATE523499T1
(de)
|
2006-07-06 |
2011-09-15 |
Array Biopharma Inc |
Cyclopenta [d]-pyrimidine als akt-proteinkinasehemmer
|
|
CA2656566C
(en)
|
2006-07-06 |
2014-06-17 |
Array Biopharma Inc. |
Dihydrofuro pyrimidines as akt protein kinase inhibitors
|
|
ATE532789T1
(de)
|
2006-07-06 |
2011-11-15 |
Array Biopharma Inc |
Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
DE102006033140A1
(de)
*
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
|
US20080207671A1
(en)
*
|
2006-07-31 |
2008-08-28 |
The Regents Of The University Of Michigan |
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
|
|
ES2729424T3
(es)
|
2006-09-20 |
2019-11-04 |
Aerie Pharmaceuticals Inc |
Inhibidores de Rho cinasa
|
|
US20080153810A1
(en)
*
|
2006-11-15 |
2008-06-26 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
WO2008070823A2
(en)
|
2006-12-07 |
2008-06-12 |
University Of South Florida |
Substrate-mimetic akt inhibitor
|
|
CN101678022A
(zh)
|
2006-12-21 |
2010-03-24 |
弗特克斯药品有限公司 |
可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
DE102007002717A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
|
US20080194557A1
(en)
*
|
2007-01-18 |
2008-08-14 |
Joseph Barbosa |
Methods and compositions for the treatment of pain, inflammation and cancer
|
|
WO2008094181A2
(en)
*
|
2007-02-01 |
2008-08-07 |
The Regents Of The University Of Michigan |
Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
EP2134175A4
(en)
*
|
2007-03-29 |
2012-01-11 |
Glaxosmithkline Llc |
HAMMER OF ACT ACTIVITY
|
|
DE102007022565A1
(de)
|
2007-05-14 |
2008-11-20 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
WO2009006567A2
(en)
*
|
2007-07-05 |
2009-01-08 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
CN101918373B
(zh)
*
|
2007-07-05 |
2013-06-05 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
US20090274698A1
(en)
*
|
2007-07-06 |
2009-11-05 |
Shripad Bhagwat |
Combination anti-cancer therapy
|
|
DK2178870T3
(en)
*
|
2007-08-17 |
2018-10-22 |
Lg Chemical Ltd |
INDOLE AND INDAZOLIC COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSE
|
|
CN103553945B
(zh)
*
|
2007-10-05 |
2015-01-07 |
奥克塞拉有限公司 |
用于治疗疾病的烷氧基化合物
|
|
EP2240455B1
(en)
|
2008-01-09 |
2012-12-26 |
Array Biopharma, Inc. |
Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
|
|
ES2422733T3
(es)
|
2008-01-09 |
2013-09-13 |
Array Biopharma Inc |
Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
|
|
JP2011513483A
(ja)
*
|
2008-03-10 |
2011-04-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼの阻害剤として有用なピリミジンおよびピリジン
|
|
AU2009239778B2
(en)
|
2008-04-24 |
2014-03-13 |
F2G Ltd |
Pyrrole antifungal agents
|
|
US8158656B2
(en)
*
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
WO2009147189A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
US8163743B2
(en)
*
|
2008-06-05 |
2012-04-24 |
GlaxoGroupLimited |
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
|
|
ES2383246T3
(es)
*
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
WO2009147188A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
EP2306825A4
(en)
*
|
2008-06-26 |
2011-12-28 |
Glaxosmithkline Llc |
HAMMER OF ACT ACTIVITY
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
JP2011530511A
(ja)
*
|
2008-08-05 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
治療用化合物
|
|
DE102008038222A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
Indazol-5-carbonsäurehydrazid-derivate
|
|
DE102008038221A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
|
DE102008038220A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
Oxadiazolderivate
|
|
AR074199A1
(es)
*
|
2008-11-20 |
2010-12-29 |
Glaxosmithkline Llc |
Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer.
|
|
CN102405047B
(zh)
*
|
2009-01-30 |
2014-07-09 |
葛兰素史密斯克莱有限责任公司 |
结晶型的n-{(1s)-2-氨基-1-[(3-氟苯基)甲基]乙基}-5-氯-4-(4-氯-1-甲基-1h-吡唑-5-基)-2-噻吩甲酰胺盐酸盐
|
|
SI2396307T1
(sl)
|
2009-02-11 |
2015-02-27 |
Merck Patent Gmbh |
Novi amino azaheterockliäśni karboksamidi
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
WO2010120854A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Glaxosmithkline Llc |
Chemical compounds
|
|
LT2899191T
(lt)
|
2009-04-30 |
2017-10-25 |
Glaxo Group Limited |
Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai
|
|
EP3828172A1
(en)
*
|
2009-05-01 |
2021-06-02 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
LT3141252T
(lt)
|
2009-06-17 |
2018-11-12 |
Vertex Pharmaceuticals Inc. |
Gripo virusų replikacijos inhibitoriai
|
|
JP5763636B2
(ja)
|
2009-08-07 |
2015-08-12 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
新規なアザ複素環化合物
|
|
US8846673B2
(en)
|
2009-08-11 |
2014-09-30 |
Bristol-Myers Squibb Company |
Azaindazoles as kinase inhibitors and use thereof
|
|
US8487102B2
(en)
*
|
2010-04-20 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Pyrrazolopyridine compounds as dual NK1/NK3 receptor antagonists
|
|
AU2011282684B2
(en)
|
2010-07-29 |
2015-05-21 |
Merck Patent Gmbh |
Cyclic amine azaheterocyclic carboxamides
|
|
UA110113C2
(xx)
|
2010-07-29 |
2015-11-25 |
|
Біциклічні азагетероциклічні карбоксаміди
|
|
CN103201263A
(zh)
*
|
2010-09-08 |
2013-07-10 |
匹兹堡高等教育联邦体系大学 |
p53-Mdm2拮抗剂
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
EP2638149B1
(en)
|
2010-11-12 |
2019-05-15 |
Georgetown University |
Immortalization of epithelial cells and methods of use
|
|
LT2643313T
(lt)
|
2010-11-24 |
2016-10-25 |
Merck Patent Gmbh |
Chinazolino karboksamido azetidinai
|
|
RU2013132681A
(ru)
|
2010-12-16 |
2015-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
|
RU2013148817A
(ru)
|
2011-04-01 |
2015-05-10 |
Дженентек, Инк. |
Комбинации соединений-ингибиторов акт и мек и способы их применения
|
|
WO2012135781A1
(en)
|
2011-04-01 |
2012-10-04 |
Genentech, Inc. |
Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
US9321760B2
(en)
|
2011-09-12 |
2016-04-26 |
Merck Patent Gmbh |
Aminopyrimidine derivatives for use as modulators of kinase activity
|
|
PT2755965T
(pt)
|
2011-09-12 |
2017-11-02 |
Merck Patent Gmbh |
Novas imidazol aminas como moduladores da atividade quinase
|
|
US20140051679A1
(en)
|
2011-10-12 |
2014-02-20 |
Univeristy Health Networks |
Kinase inhibitors and method of treating cancer with same
|
|
EA027968B1
(ru)
|
2011-12-22 |
2017-09-29 |
Мерк Патент Гмбх |
Гетероциклические карбоксамиды в качестве модуляторов активности киназ
|
|
TW201332949A
(zh)
*
|
2012-01-13 |
2013-08-16 |
Medeia Therapeutics Ltd |
具抗雄激素性質新芳醯胺衍生物
|
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
TW201427970A
(zh)
*
|
2012-10-12 |
2014-07-16 |
Univ Health Network |
激酶抑制劑及使用其治療癌症的方法
|
|
US9580443B2
(en)
|
2012-11-16 |
2017-02-28 |
Merck Patent Gmbh |
Heterocyclic derivatives as modulators of kinase activity
|
|
EP2920154B1
(en)
|
2012-11-16 |
2017-10-11 |
Merck Patent GmbH |
Novel imidazol-piperidinyl derivatives as modulators of kinase activity
|
|
NZ706418A
(en)
|
2012-11-29 |
2019-09-27 |
Merck Patent Gmbh |
Azaquinazoline carboxamide derivatives
|
|
AR095202A1
(es)
|
2013-03-11 |
2015-09-30 |
Merck Patent Gmbh |
Heterociclos como moduladores de la actividad quinasa
|
|
ES2852377T3
(es)
|
2013-03-15 |
2021-09-13 |
Aerie Pharmaceuticals Inc |
Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
|
|
CN112472699A
(zh)
|
2013-07-26 |
2021-03-12 |
种族肿瘤学公司 |
改善比生群及衍生物的治疗益处的组合方法
|
|
CN103570624B
(zh)
*
|
2013-08-06 |
2016-07-06 |
安徽世华化工有限公司 |
3-溴-5-硝基-1h-吲唑的合成工艺
|
|
US9629851B2
(en)
|
2013-09-20 |
2017-04-25 |
Stitching Het Nederlands Kanker Institut—Antoni Van Leeuwenhoek Ziekenhuis |
ROCK in combination with MAPK pathway
|
|
JP6618901B2
(ja)
|
2013-11-13 |
2019-12-11 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
LT3068776T
(lt)
|
2013-11-13 |
2019-08-12 |
Vertex Pharmaceuticals Incorporated |
Gripo virusų replikacijos inhibitoriai
|
|
EP3125935B1
(en)
|
2014-04-03 |
2019-10-23 |
Merck Patent GmbH |
Combinations of cancer therapeutics
|
|
CN107075469A
(zh)
|
2014-06-27 |
2017-08-18 |
加利福尼亚大学董事会 |
培养的哺乳动物角膜缘干细胞、其产生方法和其用途
|
|
KR101731624B1
(ko)
*
|
2014-07-01 |
2017-05-04 |
광주과학기술원 |
세포 리프로그래밍 유도용 조성물
|
|
DK3221308T3
(en)
|
2014-11-21 |
2018-12-10 |
F2G Ltd |
Antifungals
|
|
WO2016161192A1
(en)
|
2015-04-03 |
2016-10-06 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
US10100285B2
(en)
|
2015-04-03 |
2018-10-16 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
|
EP3294735B8
(en)
|
2015-05-13 |
2022-01-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
WO2017015152A1
(en)
|
2015-07-17 |
2017-01-26 |
Memorial Sloan-Kettering Cancer Center |
Combination therapy using pdk1 and pi3k inhibitors
|
|
WO2017044454A1
(en)
|
2015-09-11 |
2017-03-16 |
Propagenix Inc. |
Ex vivo proliferation of epithelial cells
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
KR102579582B1
(ko)
|
2015-11-17 |
2023-09-15 |
에어리 파마슈티컬즈, 인코포레이티드 |
키나아제 억제제 및 이의 중간체의 제조 방법
|
|
GB201609222D0
(en)
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|
|
KR102568079B1
(ko)
|
2016-08-31 |
2023-08-17 |
에어리 파마슈티컬즈, 인코포레이티드 |
안과용 조성물
|
|
AU2018243687C1
(en)
|
2017-03-31 |
2020-12-24 |
Alcon Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
RS65914B1
(sr)
*
|
2017-04-18 |
2024-10-31 |
Lilly Co Eli |
Fenil-2-hidroksi-acetilamino-2-metil-fenil jedinjenja
|
|
WO2018234354A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Grünenthal GmbH |
Novel substituted 3-indole and 3-indazole compounds as phosphodiesterase inhibitors
|
|
CN110869360B
(zh)
*
|
2017-07-12 |
2023-12-15 |
百时美施贵宝公司 |
作为rock抑制剂的苯乙酰胺类
|
|
WO2019018855A1
(en)
*
|
2017-07-21 |
2019-01-24 |
Kadmon Corporation, Llc |
ALPHA PROPELLER PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO
|
|
US11926596B2
(en)
|
2017-07-21 |
2024-03-12 |
Kadmon Corporation, Llc |
Inhibitors of Rho associated coiled-coil containing protein kinase
|
|
US11414384B2
(en)
|
2018-02-16 |
2022-08-16 |
Constellation Pharmaceuticals, Inc. |
P300/CBP hat inhibitors
|
|
WO2019161162A1
(en)
*
|
2018-02-16 |
2019-08-22 |
Constellation Pharmaceuticals, Inc. |
P300/cbp hat inhibitors
|
|
WO2020041065A1
(en)
|
2018-08-20 |
2020-02-27 |
Propagenix Inc. |
Epithelial cell spheroids
|
|
CA3110661A1
(en)
|
2018-08-29 |
2020-03-05 |
University Of Massachusetts |
Inhibition of protein kinases to treat friedreich ataxia
|
|
CA3112391A1
(en)
|
2018-09-14 |
2020-03-19 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
UY38427A
(es)
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
|
US11819503B2
(en)
|
2019-04-23 |
2023-11-21 |
F2G Ltd |
Method of treating coccidioides infection
|
|
EP4003342A1
(en)
*
|
2019-07-29 |
2022-06-01 |
Constellation Pharmaceuticals, Inc. |
Compounds for use in treating neurological disorders
|
|
BR112022001054A2
(pt)
*
|
2019-08-21 |
2022-03-15 |
Kalvista Pharmaceuticals Ltd |
Inibidores enzimáticos
|
|
CN114585606A
(zh)
|
2019-08-29 |
2022-06-03 |
希伯塞尔股份有限公司 |
抑制perk的化合物
|
|
JP7531379B2
(ja)
*
|
2019-12-31 |
2024-08-09 |
財團法人工業技術研究院 |
βアミノ酸誘導体、これを含むキナーゼ阻害剤および医薬組成物ならびにその使用
|
|
CN111217834B
(zh)
*
|
2020-02-21 |
2021-10-26 |
维眸生物科技（上海）有限公司 |
Rock激酶抑制剂的硝基氧衍生物
|
|
JP2023522784A
(ja)
|
2020-04-27 |
2023-05-31 |
ノバルティス アーゲー |
眼細胞療法のための方法及び組成物
|
|
WO2022101459A1
(en)
|
2020-11-16 |
2022-05-19 |
Merck Patent Gmbh |
Kinase inhibitor combinations for cancer treatment
|
|
CN118159645A
(zh)
|
2021-10-18 |
2024-06-07 |
埃维亚生命科学有限公司 |
组合物及使用其治疗肝纤维化的方法
|
|
EP4419120A2
(en)
|
2021-10-22 |
2024-08-28 |
Evia Life Sciences Inc. |
Methods for making extracellular vesicles, and compositions and methods of use thereof
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
WO2024052685A1
(en)
|
2022-09-09 |
2024-03-14 |
MyricX Pharma Limited |
Cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapy
|
|
CN116715634B
(zh)
*
|
2023-06-12 |
2025-11-21 |
北京新源医疗有限责任公司 |
一种化合物、药物组合物及在制备血管舒张药物中的应用
|
|
CN116891460A
(zh)
*
|
2023-07-12 |
2023-10-17 |
浙江大学 |
一种吲唑类衍生物或其药用盐及应用
|
|
CN117229217A
(zh)
*
|
2023-09-14 |
2023-12-15 |
常州大学 |
一种肾上腺素受体功能活性的别构调节剂及其制备方法和应用
|
|
WO2025088534A1
(en)
*
|
2023-10-27 |
2025-05-01 |
Dong-A St Co., Ltd. |
Bicyclic heterocycle compounds as tead inhibitor
|
|
CN117603084A
(zh)
*
|
2023-12-18 |
2024-02-27 |
江苏瑞思坦生物科技有限公司 |
肽酶神经溶素增强剂及其制备方法和应用
|
|
CN121471116B
(zh)
*
|
2026-01-08 |
2026-04-14 |
首都医科大学附属北京胸科医院 |
含有磺酰基的化合物及其制备和应用
|